Vincent Mutel

7.3k citations
85 papers · 4.9k · h-index 39

Impact in

Papers in

  • Cellular and Molecular Neuroscience 68
    • Neuroscience and Neuropharmacology Research 61
    • Neurotransmitter Receptor Influence on Behavior 10
    • Neuropeptides and Animal Physiology 9
  • Molecular Biology 57
    • Receptor Mechanisms and Signaling 36
    • Ion channel regulation and function 17
    • Nicotinic Acetylcholine Receptors Study 6
Co-authors
John A. Kemp (23 shared papers)James N.C. Kew (15 shared papers)Pari Malherbe (15 shared papers)Jürgen Wichmann (18 shared papers)Geo Adam (16 shared papers)Frédéric Knoflach (15 shared papers)Odile Kellermann (9 shared papers)John Richards (11 shared papers)
Journals
Bioorganic & Medicinal Chemistry Letters (12 papers)Neuropharmacology (8 papers)Journal of Pharmacology and Experimental Therapeutics (6 papers)Journal of Neurochemistry (5 papers)Journal of Biological Chemistry (5 papers)
Partner nations
SwitzerlandFranceUnited States

In The Last Decade

Vincent Mutel

84 papers receiving 4.7k citations

Peers

Vincent Mutel
Comparison fields: 5 of 105
  • Cellular and Molecular Neuroscience 3.4k
  • Biological Psychiatry 189
  • Developmental Neuroscience 165
  • Neurology 337
  • Molecular Biology 2.8k
Replace Bryan G. Johnson with:
Bryan G. Johnson United States
Serge Bischoff Switzerland
Frédéric Knoflach Switzerland
Peter D. Suzdak Denmark
James N.C. Kew United Kingdom
Kevin K. Ogden United States
Hiroshi Ujike Japan
Mark A. Varney United States
Katie M. Vance United States
Aline Dumuis France
Vincent Mutel relative to Bryan G. Johnson United States Bryan G. Johnson's profile →
Citations per field
00.5×1.5×1.9×
Bryan G. Johnson · 1×
Citations per year

Countries citing papers authored by Vincent Mutel

Since Specialization
Citations

This map shows the geographic impact of Vincent Mutel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Mutel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Mutel more than expected).

Fields of papers citing papers by Vincent Mutel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Mutel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Mutel. The network helps show where Vincent Mutel may publish in the future.

Co-authors

The 25 scholars most cited alongside Vincent Mutel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Vincent Mutel Line = papers co-authored together Vincent Mutel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Ro 25–6981, a Highly Potent and Selective Blocker of N-Methyl-d-aspartate Receptors Containing the NR2B Subunit. Characterization in Vitro
Journal of Pharmacology and Experimental Therapeutics ·G. Fischer, Vincent Mutel, Gerhard Trube, Pari Malherbe, James N.C. Kew, E. MOHACSI, M. Heitz, John A. Kemp
1997422
2
5-HT2C Receptor Agonists: Pharmacological Characteristics and Therapeutic Potential
Journal of Pharmacology and Experimental Therapeutics ·Joel R. Martin, Michael Bös, F. Jenck, Jean‐Luc Moreau, Vincent Mutel, Andrew J. Sleight, J. Wichmann, John S. Andrews, Hermanus Henricus Gerardus Berendsen, C.L.E. Broekkamp, G.S.F. Ruigt, C. Köhler, A.M.L. van Delft
1998300
3
Fenobam: A Clinically Validated Nonbenzodiazepine Anxiolytic Is a Potent, Selective, and Noncompetitive mGlu5 Receptor Antagonist with Inverse Agonist Activity
Journal of Pharmacology and Experimental Therapeutics ·Richard H. Porter, Georg Jaeschke, Will Spooren, Theresa M. Ballard, Bernd Büttelmann, Sabine Kolczewski, Jens‐Uwe Peters, Eric Prinssen, Jürgen Wichmann, Eric Vieira, Andreas Mühlemann, S. Gatti, Vincent Mutel, Pari Malherbe
2005270
4
Positive allosteric modulators of metabotropic glutamate 1 receptor: Characterization, mechanism of action, and binding site
Proceedings of the National Academy of Sciences ·Frédéric Knoflach, Vincent Mutel, Synèse Jolidon, James N.C. Kew, Pari Malherbe, Eric Vieira, Jürgen Wichmann, John A. Kemp
2001205
5
Developmental Changes in NMDA Receptor Glycine Affinity and Ifenprodil Sensitivity Reveal Three Distinct Populations of NMDA Receptors in Individual Rat Cortical Neurons
Journal of Neuroscience ·James N.C. Kew, J. G. Richards, Vincent Mutel, John A. Kemp
1998203
6
NADPH oxidase and extracellular regulated kinases 1/2 are targets of prion protein signaling in neuronal and nonneuronal cells
Proceedings of the National Academy of Sciences ·Benoı̂t Schneider, Vincent Mutel, Mathéa Pietri, Myriam Ermonval, Sophie Mouillet‐Richard, Odile Kellermann
2003164
7
Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders
Behavioural Pharmacology ·Will Spooren, T.M. Ballard, F. Gasparini, Marianne Amalric, Vincent Mutel, Robert D. Schreiber
2003156
8
Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent
Neuropharmacology ·Guy A. Higgins, Theresa M. Ballard, James N.C. Kew, John Richards, John A. Kemp, Geo Adam, Thomas J. Woltering, Shigetada Nakanishi, Vincent Mutel
2004146
9
In Vitro Binding Properties in Rat Brain of [3H]Ro 25‐6981, a Potent and Selective Antagonist of NMDA Receptors Containing NR2B Subunits
Journal of Neurochemistry ·Vincent Mutel, Danièle Buchy, Agnès Klingelschmidt, Jürg Messer, Zaiga Bleuel, John A. Kemp, John Richards
1998145
10
Severe Impairment of NMDA Receptor Function in Mice Carrying Targeted Point Mutations in the Glycine Binding Site Results in Drug-Resistant Nonhabituating Hyperactivity
Journal of Neuroscience ·Theresa M. Ballard, Meike Pauly-Evers, Guy A. Higgins, Abdel‐Mouttalib Ouagazzal, Vincent Mutel, Edilio Borroni, John A. Kemp, Horst Bluethmann, James N.C. Kew
2002133
11
Mutational Analysis and Molecular Modeling of the Allosteric Binding Site of a Novel, Selective, Noncompetitive Antagonist of the Metabotropic Glutamate 1 Receptor
Journal of Biological Chemistry ·Pari Malherbe, Nicole A. Kratochwil, Frédéric Knoflach, Marie‐Thérèse Zenner, James N.C. Kew, Claudia Kratzeisen, Hans Peter Maerki, Geo Adam, Vincent Mutel
2003117
12
Regulation by Neurotransmitter Receptors of Serotonergic or Catecholaminergic Neuronal Cell Differentiation
Journal of Biological Chemistry ·Sophie Mouillet‐Richard, Vincent Mutel, Sylvain Loric, Claire Tournois, Jean‐Marie Launay, Odile Kellermann
2000111
13
Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs
European Journal of Pharmacology ·François Jenck, Jean-Luc Moreau, Vincent Mutel, James R. Martin, W. Haefely
1993102
14
Functional Consequences of Reduction in NMDA Receptor Glycine Affinity in Mice Carrying Targeted Point Mutations in the Glycine Binding Site
Journal of Neuroscience ·James N.C. Kew, Anja Köester, Jean‐Luc Moreau, François Jenck, Abdel‐Mouttalib Ouagazzal, Vincent Mutel, J. G. Richards, Gerhard Trube, Guenther Fischer, Alexandra Montkowski, W. Hundt, Rainer K. Reinscheid, Meike Pauly-Evers, John A. Kemp, Horst Bluethmann
200090
15
ADX71743, a Potent and Selective Negative Allosteric Modulator of Metabotropic Glutamate Receptor 7: In Vitro and In Vivo Characterization
Journal of Pharmacology and Experimental Therapeutics ·Mikhail Kalinichev, Mélanie Rouillier, Françoise Girard, Isabelle Royer-Urios, Bruno Bournique, Terry Finn, Delphine Charvin, Brice Campo, Emmanuel Le Poul, Vincent Mutel, Sonia Poli, S. Neale, T.E. Salt, Robert Lütjens
201290
16
In Vitro Binding Characteristics of a New Selective Group II Metabotropic Glutamate Receptor Radioligand, [3H]LY354740, in Rat Brain
Molecular Pharmacology ·Hervé Schaffhauser, John Richards, Jayne Cartmell, Sylvie Chaboz, John A. Kemp, Agnès Klingelschmidt, Jürg Messer, Heinz Stadler, Thomas J. Woltering, Vincent Mutel
199885
17
9H-Xanthene-9-carboxylic acid [1,2,4]oxadiazol-3-yl- and (2H-tetrazol-5-yl)-amides as potent, orally available mGlu1 receptor enhancers
Bioorganic & Medicinal Chemistry Letters ·Eric Vieira, Jörg Huwyler, Synèse Jolidon, Frédéric Knoflach, Vincent Mutel, Jürgen Wichmann
200584
18
Cross-talk between 5-Hydroxytryptamine Receptors in a Serotonergic Cell Line
Journal of Biological Chemistry ·Claire Tournois, Vincent Mutel, Philippe Manivet, Jean‐Marie Launay, Odile Kellermann
199878
19
Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: Effects on apparent agonist affinities
Biochemical Pharmacology ·Andrew J. Sleight, Nico J. Stam, Vincent Mutel, Patrick Vanderheyden
199677
20
Characterization of [3H]‐(2S,2′R,3′R)‐2‐(2′,3′‐dicarboxy‐ cyclopropyl)glycine ([3H]‐DCG IV) binding to metabotropic mGlu2 receptor‐transfected cell membranes
British Journal of Pharmacology ·Jayne Cartmell, Geo Adam, Sylvie Chaboz, Robert Henningsen, John A. Kemp, Agnès Klingelschmidt, Veit Metzler, Frederick J. Monsma, Hervé Schaffhauser, Jürgen Wichmann, Vincent Mutel
199873

About Vincent Mutel

Vincent Mutel is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology, Organic Chemistry, Cognitive Neuroscience and Materials Chemistry, having authored 85 papers that have together received 4.9k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (61 papers), Receptor Mechanisms and Signaling (36 papers), Ion channel regulation and function (17 papers), Neurotransmitter Receptor Influence on Behavior (10 papers), Neuropeptides and Animal Physiology (9 papers), Photochromic and Fluorescence Chemistry (7 papers), Memory and Neural Mechanisms (7 papers) and Nicotinic Acetylcholine Receptors Study (6 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (3.4k citations), Biological Psychiatry (189 citations), Developmental Neuroscience (165 citations), Neurology (337 citations) and Molecular Biology (2.8k citations). Vincent Mutel has collaborated with scholars based in Switzerland, France and United States. Frequent co-authors include John A. Kemp, James N.C. Kew, Pari Malherbe, Jürgen Wichmann, Geo Adam, Frédéric Knoflach, Odile Kellermann, John Richards, Eric Vieira and Gerhard Trube. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Neuropharmacology, Journal of Pharmacology and Experimental Therapeutics, Journal of Neurochemistry and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bryan G. JohnsonBreakdown of academic impact, for papers by Serge BischoffBreakdown of academic impact, for papers by Frédéric KnoflachBreakdown of academic impact, for papers by Peter D. SuzdakBreakdown of academic impact, for papers by James N.C. KewBreakdown of academic impact, for papers by Kevin K. OgdenBreakdown of academic impact, for papers by Hiroshi UjikeBreakdown of academic impact, for papers by Mark A. VarneyBreakdown of academic impact, for papers by Katie M. VanceBreakdown of academic impact, for papers by Aline Dumuis